TX103 CAR-T cells

TX103 CAR-T cells · Tcelltech Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TX103 CAR-T cells, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors [Phase 1]